C-fos-induced growth factor

This secreted protein undergoes a complex proteolytic maturation, generating multiple processed forms that bind and activate VEGFR-2 and VEGFR-3 receptors.The structure and function of this protein is similar to those of vascular endothelial growth factor C.[5] Lymph node metastasis is very often associated with several types of human malignancies.Cancer cells’ journey to lymph node takes place largely through lymphatic tunnel located in and around of primary tumor.VEGF-D has been established to be over-expressed in both tumor tissues and patients’ serum samples in several types of human cancer.In experimental mice study, genetically modified tumor cell that was forced to produce VEGF-D protein have been established to boost up regional lymph nodes metastases.
AliasesHomoloGeneGeneCardsX chromosome (human)RNA expressionGene ontologyOrthologsEntrezEnsemblUniProtPubMedWikidatavascular endothelial growth factorVEGFR-2VEGFR-3UCSC Genome BrowserBibcodeGrowth factorsFibroblastFGF receptorFGF15/19EGF-like domainHB-EGFTGFβ pathwayTGFβ1TGFβ2TGFβ3Insulin/IGF/Relaxin familyInsulinInsulin-like growth factorRelaxin family peptide hormonesRelaxinPlatelet-derivedVascular endothelialVEGF-AVEGF-BVEGF-CVEGF-DHepatocyteGrowth factor receptormodulatorsAngiopoietinAngiopoietin 1Angiopoietin 4Angiopoietin 2RebastinibEvinacumabNesvacumabAxokineEGF (ErbB)EGF(ErbB1/HER1)AmphiregulinBetacellulinEGF (urogastrone)EpigenEpiregulinHeparin-binding EGF-like growth factor (HB-EGF)MuroderminNepiderminTransforming growth factor alpha (TGFα)AfatinibBrigatinibCanertinibDacomitinibErlotinibGefitinibGrandininIcotinibLapatinibNeratinibOsimertinibVandetanibCetuximabDepatuxizumab mafodotinFutuximabImgatuzumabMatuzumabNecitumumabNimotuzumabPanitumumabZalutumumabErbB2/HER2ErtumaxomabPertuzumabTrastuzumabTrastuzumab deruxtecanTrastuzumab emtansineMubritinibTucatinibErbB3/HER3Neuregulins (heregulins)6 (neuroglycan C)DuligotumabPatritumabSeribantumabErbB4/HER42 (bFGF)10 (KGF2)SelpercatinibTraferminPaliferminSpriferminInfigratinibBurosumabHGF (c-Met)FosgonimetonHepatocyte growth factorDihexa (PNB-0408)CabozantinibCapmatinibCrizotinibForetinibTivantinibVolitinibEmibetuzumabFiclatuzumabFlanvotumabOnartuzumabRilotumumabTelisotuzumab vedotindes(1-3)IGF-1Insulin-like growth factor-1 (somatomedin C)IGF-1 LR3Insulin-like growth factor-2 (somatomedin A)MecaserminMecasermin rinfabateLinsitinibCixutumumabDalotuzumabFigitumumabGanitumabRobatumumabTeprotumumabDusigitumabTrofinetideLNGF (p75NTR)BNN-20BNN-27CenegerminDHEA-SDexamethasoneTestosteroneFasinumabFrunevetmabFulranumabTanezumabBecaplerminPlatelet-derived growth factorAvapritinibAxitinibCrenolanibImatinibLenvatinibMasitinibMotesanibNintedanibPazopanibRadotinibQuizartinibRipretinibSunitinibSorafenibToceranibOlaratumabRamucirumabTovetumabRET (GFL)GFRα1Glial cell line-derived neurotrophic factor (GDNF)GFRα2Neurturin (NRTN)GFRα3Artemin (ARTN)GFRα4Persephin (PSPN)SCF (c-Kit)AncestimStem cell factorDasatinibNilotinibAmitriptylineTavilermideEntrectinibLarotrectinibLestaurtinib4'-DMA-7,8-DHF7,8-DHF7,8,3'-THFDeoxygeduninDeprenylDiosmetinLM22A-4N-AcetylserotoninNorwogonin (5,7,8-THF)ANA-12Cyclotraxin BGossypetin (3,5,7,8,3',4'-HHF)Placental growth factor (PGF)D (FIGF)CediranibFruquintinibPegaptanibRegorafenibSemaxanibTivozanibAlacizumab pegolBevacizumabIcrucumabRanibizumabAfliberceptAdrenomedullinColony-stimulating factorsConnective tissue growth factor (CTGF)EphrinsErythropoietinGlucose-6-phosphate isomerase (GPI; PGI, PHI, AMF)Glia maturation factor (GMF)Hepatoma-derived growth factor (HDGF)InterleukinsT-cell growth factorsLeukemia inhibitory factor (LIF)Macrophage-stimulating protein (MSP; HLP, HGFLP)Midkine (NEGF2)Migration-stimulating factor (MSF; PRG4)OncomodulinPituitary adenylate cyclase-activating peptide (PACAP)PleiotrophinRenalaseThrombopoietinWnt signaling proteinsCerebrolysin